Page last updated: 2024-11-08

pentylenetetrazole and Cardiomyopathies

pentylenetetrazole has been researched along with Cardiomyopathies in 1 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sommer, H1
Quandt, J1

Other Studies

1 other study available for pentylenetetrazole and Cardiomyopathies

ArticleYear
[Brain tissue damage following the management of cardiazol-induced convulsions. Animal experimental contribution].
    Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete, 1969, Volume: 37, Issue:2

    Topics: Animals; Brain; Cardiomyopathies; Cats; Cerebellum; Electroconvulsive Therapy; Electroshock; Frontal

1969